Rewind Therapeutics has raised further funding that has seen Sunstone Life Science Ventures joining as a new investor. The funding round has seen participation of current investors Boehringer Ingelheim Venture Fund, M. Ventures, PMV, Gemma Frisius Fonds, and CD3/ KU Leuven.